Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy

In patients with treatment‐resistant epilepsy (TRE), cannabidiol (CBD) produces variable improvement in seizure control. Patients in the University of Alabama at Birmingham CBD Expanded Access Program (EAP) were enrolled in the genomic study and genotyped using the Affymetrix Drug Metabolizing Enzym...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Brittney H., Beasley, T. Mark, Amaral, Michelle, Szaflarski, Jerzy P., Gaston, Tyler, Perry Grayson, Leslie, Standaert, David G, Bebin, E. Martina, Limdi, Nita A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530979/
https://www.ncbi.nlm.nih.gov/pubmed/34464454
http://dx.doi.org/10.1002/cpt.2408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530979/
https://www.ncbi.nlm.nih.gov/pubmed/34464454
http://dx.doi.org/10.1002/cpt.2408

Ejemplares similares